Search Results - "D’Atri, Domenico"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Cell-specific cargo delivery using synthetic bacterial spores by Kong, Minsuk, D’Atri, Domenico, Bilotta, Maria Teresa, Johnson, Bailey, Updegrove, Taylor B., Gallardo, Devorah L., Machinandiarena, Federico, Wu, I-Lin, Constantino, Maira Alves, Hewitt, Stephen M., Tanner, Kandice, Fitzgerald, David J., Ramamurthi, Kumaran S.

    Published in Cell reports (Cambridge) (31-01-2023)
    “…Delivery of cancer therapeutics to non-specific sites decreases treatment efficacy while increasing toxicity. In ovarian cancer, overexpression of the cell…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Nano-ghosts: Novel biomimetic nano-vesicles for the delivery of antisense oligonucleotides by Oieni, Jacopo, Lolli, Andrea, D'Atri, Domenico, Kops, Nicole, Yayon, Avner, van Osch, Gerjo J.V.M., Machluf, Marcelle

    Published in Journal of controlled release (10-05-2021)
    “…Antisense oligonucleotides (ASOs) carry an enormous therapeutic potential in different research areas, however, the lack of appropriate carriers for their…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Nano-Ghosts: Biomimetic membranal vesicles, technology and characterization by Oieni, Jacopo, Levy, Lior, Letko Khait, Nitzan, Yosef, Liat, Schoen, Beth, Fliman, Miguel, Shalom-Luxenburg, Hagit, Malkah Dayan, Natali, D'Atri, Domenico, Cohen Anavy, Noa, Machluf, Marcelle

    Published in Methods (San Diego, Calif.) (01-05-2020)
    “…•Investigation of Nano-Ghosts manufacturing-process robustness.•Examination of post-production shelf-life through stability and storage studies.•Demonstration…”
    Get full text
    Journal Article
  6. 6

    Abstract 1739: Cell-specific cargo delivery using synthetic bacterial spores by D'Atri, Domenico, Kong, Minsuk, Bilotta, Maria Teresa, Tanner, Kandice, Fitzgerald, David J., Ramamurthi, Kumaran S.

    Published in Cancer research (Chicago, Ill.) (15-06-2022)
    “…Abstract The overexpression of the cell surface receptor “HER-2” is a common marker for many breast and ovarian cancers. New treatments for these cancers…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Anti-HER2 cell specific doxorubicin delivery using synthetic bacterial spores for resistant ovarian cancer treatment by D’Atri, Domenico, Kong, Minsuk, Bilotta, Maria Teresa, Tanner, Kandice, Fitzgerald, David, Ramamurthi, Kumaran S.

    Published in The Journal of immunology (1950) (01-05-2023)
    “…Abstract Delivery of cancer therapeutics to non-specific sites decreases treatment efficacy while increasing toxicity. In ovarian cancer, overexpression of the…”
    Get full text
    Journal Article